Bloomberg Runs Steve Jobs' Obituary
For whatever reason, the Bloomberg financial newswire decided to update its 17-page Steve Jobs obituary today. It's true that the secretive Apple CEO's battle with pancreatic cancer, and speculation over his health, rattled some investors earlier …
Context & Ripple Effects
Questions about Jobs’s health had already become a market issue: health concerns were weighing on Apple’s share price, while Jobs had separately given a New York Times columnist an account before informing Apple shareholders. Bloomberg’s obituary publication lands in that information vacuum, where an editorial error can be read as a corporate signal.
First-order effects
- Bloomberg’s mistaken obituary publication risks damaging its credibility with investors and readers who treat its wire output as market-relevant information.
- Apple and Jobs face intensified pressure to address health speculation because the error arrives after health reports had already affected the company’s share price.
Second-order effects
- News organizations covering Apple have a stronger incentive to distinguish verified health disclosures from rumor, since inaccurate reporting can amplify trading-sensitive uncertainty.
- Apple’s investor-relations communications become more consequential when outside reporting, rather than company disclosure, is shaping the market narrative around its chief executive.
Third-order effects
- The episode points to executive health becoming an operational disclosure risk for founder-led public companies, with newsroom publishing controls part of the information infrastructure investors rely on.
The trend: Market sensitivity to a prominent CEO’s health is pushing corporate disclosure and financial-news accuracy into the same high-stakes signal chain.